Subscribe to learn about new product features, the latest in technology, solutions, and updates.
Published in BIOTECanada Insights Magazine WHEN A BIOTECH STARTUP gears for its next major trial, the focus is often on the science and funding—but geography plays a
Drug development is one of the most challenging endeavors in science. The journey from laboratory to pharmacy typically takes over a decade, costs around $1-3
Inside Vincere’s quest to transform treatments against neurodegeneration using artificial intelligence What happens when a software engineer marries a neuroscientist? In Andy Lee and Dr.
It wasn’t that long ago when booking travel accommodations meant settling between two often unsatisfying options: pricey chain hotels with cookie-cutter service, or uncertain stays
Australia has become a popular location for US biopharma companies to conduct R&D operations, thanks to the tax offsets available under its well-known Research and
More than 90% of drug candidates never make it to market. Many potential treatments fail not because the science is flawed but due to poor
Picture this scenario: You’ve transitioned from an investigator-driven IND to a commercial submission, only to discover your CMC data falls short of requirements. Suddenly, you’re
The biotech industry is experiencing significant shifts following President Trump’s return to office. If you’re a drug developer watching these developments unfold, you might be
Cell therapy is an advanced approach for treating rare or complex disorders. Innovations in this field allow us to treat patients more effectively with better
The United States is one of the largest and most influential markets for pharmaceuticals, making it an important destination for many global clinical development programs.
Your drug development project’s acceptance and success depend heavily on your IND application. Getting it right the first time is critical. Holding a pre-IND meeting
Hippie Counter-Culture or Wonder Drugs? In recent years, the resurgence of interest in psychedelic substances as potential therapeutic tools has captured both scientific curiosity and
Innovative approaches in developing T-cell-engaging molecules are shifting the idea of what’s possible in our medical landscape. To see these transformative immunotherapies change lives, developers
